Company Info

Year Established
2021

Contacts

Maria Reitzinger, BA
Head of Finance & Administration

Randolf Kerschbaumer, PhD
Co-Founder & CEO

Michael Thiele, PhD
Co-Founder & CSO

Alexander Schinagl, PhD
Co-Founder & CTO

Company Description

OncoOne is committed to the development of pioneering and best-in-class therapeutics targeting oxMIF, the druggable isoform of MIF.